{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T03:23:05Z","timestamp":1743132185925,"version":"3.40.3"},"publisher-location":"Cham","reference-count":81,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783030502478"},{"type":"electronic","value":"9783030502478"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/978-3-030-50247-8_18-1","type":"book-chapter","created":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T16:18:25Z","timestamp":1676045905000},"page":"1-23","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evidence of the Impact of Harm Minimization Programs"],"prefix":"10.1007","author":[{"given":"Fernanda S.","family":"Tonin","sequence":"first","affiliation":[]},{"given":"Fernando","family":"Fernandez-Llimos","sequence":"additional","affiliation":[]},{"given":"Filipa","family":"Alves da Costa","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2023,2,11]]},"reference":[{"issue":"2","key":"18-1_CR1","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.japh.2021.10.015","volume":"62","author":"J Agley","year":"2021","unstructured":"Agley J, Meyerson BE, Eldridge LA, Crosby RA, Bentele KG, Jun M, et al. Exploration of pharmacist comfort with harm reduction behaviors: cross-sectional latent class analysis. J Am Pharm Assoc. (2003. 2021;62(2):432\u201340.","journal-title":"J Am Pharm Assoc"},{"key":"18-1_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2021.103237","volume":"93","author":"F Ali","year":"2021","unstructured":"Ali F, Russell C, Nafeh F, Rehm J, LeBlanc S, Elton-Marshall T. Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID-19 global pandemic: a national qualitative assessment in Canada. Int J Drug Policy. 2021;93:103237.","journal-title":"Int J Drug Policy"},{"issue":"1_suppl","key":"18-1_CR3","doi-asserted-by":"publisher","first-page":"100S","DOI":"10.1177\/0033354920922975","volume":"135","author":"B Ansari","year":"2020","unstructured":"Ansari B, Tote KM, Rosenberg ES, Martin EG. A rapid review of the impact of systems-level policies and interventions on population-level outcomes related to the opioid epidemic, United States and Canada, 2014\u20132018. Public Health Rep. 2020;135(1_suppl):100S\u201327S.","journal-title":"Public Health Rep"},{"issue":"6","key":"18-1_CR4","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1111\/add.15324","volume":"116","author":"T Antoniou","year":"2021","unstructured":"Antoniou T, Martins D, Campbell T, Tadrous M, Munro C, Leece P, et al. Impact of policy changes on the provision of naloxone by pharmacies in Ontario, Canada: a population-based time-series analysis. Addiction. 2021;116(6):1514\u201320.","journal-title":"Addiction"},{"issue":"1","key":"18-1_CR5","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/ije\/dyt243","volume":"43","author":"EJ Aspinall","year":"2014","unstructured":"Aspinall EJ, Nambiar D, Goldberg DJ, Hickman M, Weir A, Van Velzen E, et al. Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis. Int J Epidemiol. 2014;43(1):235\u201348.","journal-title":"Int J Epidemiol"},{"issue":"8","key":"18-1_CR6","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1111\/tmi.12890","volume":"22","author":"G Awungafac","year":"2017","unstructured":"Awungafac G, Delvaux T, Vuylsteke B. Systematic review of sex work interventions in sub-Saharan Africa: examining combination prevention approaches. Tropical Med Int Health. 2017;22(8):971\u201393.","journal-title":"Tropical Med Int Health"},{"issue":"5","key":"18-1_CR7","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1111\/add.13265","volume":"111","author":"SM Bird","year":"2016","unstructured":"Bird SM, McAuley A, Perry S, Hunter C. Effectiveness of Scotland\u2019s National Naloxone Programme for reducing opioid-related deaths: a before (2006\u201310) versus after (2011\u201313) comparison. Addiction. 2016;111(5):883\u201391.","journal-title":"Addiction"},{"issue":"2","key":"18-1_CR8","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1016\/j.sapharm.2021.06.002","volume":"18","author":"AF Bonetti","year":"2022","unstructured":"Bonetti AF, Tonin FS, Lucchetta RC, Pontarolo R, Fernandez-Llimos F. Methodological standards for conducting and reporting meta-analyses: ensuring the replicability of meta-analyses of pharmacist-led medication review. Res Social Adm Pharm. 2022;18(2):2259\u201368.","journal-title":"Res Social Adm Pharm"},{"issue":"12 Pt 1","key":"18-1_CR9","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/S0755-4982(06)74906-5","volume":"35","author":"N Bonnet","year":"2006","unstructured":"Bonnet N. Pharmacy syringe exchange program for injection drug users. Presse Med. 2006;35(12 Pt 1):1811\u20138.","journal-title":"Presse Med"},{"key":"18-1_CR10","unstructured":"British Columbia Coroners Service. Illicit drug toxicity deaths in bc January 1, 2010 \u2013 May 31, 2020. 2020. Available at https:\/\/www2gov.bc.ca\/assets\/gov\/birth-adoption-death-marriage-and-divorce\/deaths\/coroners-service\/statistical\/illicit-drug.pdf. Accessed 10 Jan 2022."},{"key":"18-1_CR11","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.drugpo.2019.05.011","volume":"72","author":"M Caven","year":"2019","unstructured":"Caven M, Malaguti A, Robinson E, Fletcher E, Dillon JF. Impact of Hepatitis C treatment on behavioural change in relation to drug use in people who inject drugs: a systematic review. Int J Drug Policy. 2019;72:169\u201376.","journal-title":"Int J Drug Policy"},{"key":"18-1_CR12","unstructured":"Centers for Disease Control and Prevention \u2013 CDC. Viral hepatitis surveillance report 2018 \u2013 Hepatitis C. 2019. Available at https:\/\/www.cdc.gov\/hepatitis\/statistics\/2018surveillance\/HepC.htm. Accessed 12 Jan 2022."},{"key":"18-1_CR13","unstructured":"Centers for Disease Control and Prevention \u2013 CDC. HIV surveillance report, 2018 (Updated). 2020. Available at http:\/\/www.cdc.gov\/hiv\/library\/reports\/hiv-surveillance.html. Accessed 12 Jan 2022."},{"issue":"4","key":"18-1_CR14","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/dar.12400","volume":"37","author":"KJ Chronister","year":"2018","unstructured":"Chronister KJ, Lintzeris N, Jackson A, Ivan M, Dietze PM, Lenton S, et al. Findings and lessons learnt from implementing Australia\u2019s first health service based take-home naloxone program. Drug Alcohol Rev. 2018;37(4):464\u201371.","journal-title":"Drug Alcohol Rev"},{"issue":"11","key":"18-1_CR15","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/j.drugpo.2015.05.001","volume":"26","author":"JT Coats","year":"2015","unstructured":"Coats JT, Dillon JF. The effect of introducing point-of-care or dried blood spot analysis on the uptake of hepatitis C virus testing in high-risk populations: a systematic review of the literature. Int J Drug Policy. 2015;26(11):1050\u20135.","journal-title":"Int J Drug Policy"},{"issue":"2","key":"18-1_CR16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jsat.2006.04.002","volume":"31","author":"MM Copenhaver","year":"2006","unstructured":"Copenhaver MM, Johnson BT, Lee IC, Harman JJ, Carey MP, Team SR. Behavioral HIV risk reduction among people who inject drugs: meta-analytic evidence of efficacy. J Subst Abus Treat. 2006;31(2):163\u201371.","journal-title":"J Subst Abus Treat"},{"issue":"1","key":"18-1_CR17","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12954-017-0156-z","volume":"14","author":"SM Davis","year":"2017","unstructured":"Davis SM, Daily S, Kristjansson AL, Kelley GA, Zullig K, Baus A, et al. Needle exchange programs for the prevention of hepatitis C virus infection in people who inject drugs: a systematic review with meta-analysis. Harm Reduct J. 2017;14(1):25.","journal-title":"Harm Reduct J"},{"key":"18-1_CR18","unstructured":"Davoli M, Simon R, Griffiths P. European Monitoring Centre for Drugs and Drug Addiction \u2013 EMCDDA. Harm reduction: evidence, impacts and challenges. Current and future perspectives on harm reduction in the European Union. 2010. Available at https:\/\/www.emcdda.europa.eu\/publications\/monographs\/harm-reduction_en. Accessed 12 Jan 2022."},{"key":"18-1_CR19","unstructured":"Department of Health \u2013 Australian Government. Topic 6: harm minimisation in AOD work. Module 5: young people, society and AOD: learner\u2019s workbook. 2004. www.health.gov.au"},{"key":"18-1_CR20","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1471-2458-13-53","volume":"13","author":"DC Des Jarlais","year":"2013","unstructured":"Des Jarlais DC, Feelemyer JP, Modi SN, Abdul-Quader A, Hagan H. High coverage needle\/syringe programs for people who inject drugs in low and middle income countries: a systematic review. BMC Public Health. 2013;13:53.","journal-title":"BMC Public Health"},{"key":"18-1_CR21","unstructured":"Dire\u00e7\u00e3o Geral de Sa\u00fade. Programa Troca de Seringas [portuguese]. 2018. Available at https:\/\/www.sns.gov.pt\/noticias\/2018\/12\/05\/programa-troca-de-seringas-2\/. Accessed 23 Aug 2021."},{"key":"18-1_CR22","unstructured":"Elflein J. Global drug use \u2013 statistics & facts. 2021. Available at https:\/\/www.statista.com\/topics\/7786\/global-drug-use\/#dossierKeyfigures. Accessed 10 Jan 2022."},{"key":"18-1_CR23","volume-title":"European drug report 2021: trends and developments","author":"European Monitoring Centre for Drugs and Drug Addiction","year":"2021","unstructured":"European Monitoring Centre for Drugs and Drug Addiction. European drug report 2021: trends and developments. Luxembourg: Publications Office of the European Union; 2021. https:\/\/www.emcdda.europa.eu\/publications\/edr\/trends-developments\/2021_en"},{"key":"18-1_CR24","unstructured":"European Monitoring Centre for Drugs and Drug Addiction \u2013 EMCDDA. Impact of COVID-19 on patterns of drug use and drug-related harms in Europe. 2020. Available at https:\/\/www.emcddaeuropaeu\/system\/files\/publications\/13130\/EMCDDA-Trendspotter-Covid-19-Wave-2_1pdf. Accessed 11 Jan 2022."},{"issue":"1","key":"18-1_CR25","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s12889-017-4210-2","volume":"17","author":"RM Fernandes","year":"2017","unstructured":"Fernandes RM, Cary M, Duarte G, Jesus G, Alarcao J, Torre C, et al. Effectiveness of needle and syringe programmes in people who inject drugs \u2013 an overview of systematic reviews. BMC Public Health. 2017;17(1):309.","journal-title":"BMC Public Health"},{"key":"18-1_CR26","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1186\/1471-2458-10-721","volume":"10","author":"M Gillies","year":"2010","unstructured":"Gillies M, Palmateer N, Hutchinson S, Ahmed S, Taylor A, Goldberg D. The provision of non-needle\/syringe drug injecting paraphernalia in the primary prevention of HCV among IDU: a systematic review. BMC Public Health. 2010;10:721.","journal-title":"BMC Public Health"},{"issue":"1","key":"18-1_CR27","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12954-018-0267-1","volume":"15","author":"MC Greene","year":"2018","unstructured":"Greene MC, Kane JC, Khoshnood K, Ventevogel P, Tol WA. Challenges and opportunities for implementation of substance misuse interventions in conflict-affected populations. Harm Reduct J. 2018;15(1):58.","journal-title":"Harm Reduct J"},{"key":"18-1_CR28","unstructured":"Harm Reduction International \u2013 HRI. The global state of harm reduction. 2020. Available at https:\/\/www.hriglobal\/files\/2021\/03\/04\/Global_State_HRI_2020_BOOK_FA_Webpdf. Accessed 12 Jan 2022."},{"issue":"2","key":"18-1_CR29","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.drugalcdep.2005.06.008","volume":"81","author":"KG Heinzerling","year":"2006","unstructured":"Heinzerling KG, Kral AH, Flynn NM, Anderson RL, Scott A, Gilbert ML, et al. Unmet need for recommended preventive health services among clients of California syringe exchange programs: implications for quality improvement. Drug Alcohol Depend. 2006;81(2):167\u201378.","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"18-1_CR30","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.japh.2019.06.019","volume":"59","author":"LG Hill","year":"2019","unstructured":"Hill LG, Evoy KE, Reveles KR. Pharmacists are missing an opportunity to save lives and advance the profession by embracing opioid harm reduction. J Am Pharm Assoc (2003). 2019;59(6):779\u201382.","journal-title":"J Am Pharm Assoc (2003)"},{"issue":"3","key":"18-1_CR31","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10461-008-9483-0","volume":"13","author":"Y Hong","year":"2009","unstructured":"Hong Y, Li X. HIV\/AIDS behavioral interventions in China: a literature review and recommendation for future research. AIDS Behav. 2009;13(3):603\u201313.","journal-title":"AIDS Behav"},{"issue":"3","key":"18-1_CR32","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/1468-0009.12210","volume":"94","author":"JP Ioannidis","year":"2016","unstructured":"Ioannidis JP. The mass production of redundant, misleading, and conflicted systematic reviews and meta-analyses. Milbank Q. 2016;94(3):485\u2013514.","journal-title":"Milbank Q"},{"issue":"2","key":"18-1_CR33","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.drugpo.2006.12.002","volume":"18","author":"KS Irwin","year":"2007","unstructured":"Irwin KS, Fry CL. Strengthening drug policy and practice through ethics engagement: an old challenge for a new harm reduction. Int J Drug Policy. 2007;18(2):75\u201383.","journal-title":"Int J Drug Policy"},{"issue":"2","key":"18-1_CR34","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.drugpo.2011.08.005","volume":"23","author":"MM Islam","year":"2012","unstructured":"Islam MM, Topp L, Day CA, Dawson A, Conigrave KM. The accessibility, acceptability, health impact and cost implications of primary healthcare outlets that target injecting drug users: a narrative synthesis of literature. Int J Drug Policy. 2012;23(2):94\u2013102.","journal-title":"Int J Drug Policy"},{"issue":"5","key":"18-1_CR35","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.drugpo.2010.02.001","volume":"21","author":"L Jones","year":"2010","unstructured":"Jones L, Pickering L, Sumnall H, McVeigh J, Bellis MA. Optimal provision of needle and syringe programmes for injecting drug users: a systematic review. Int J Drug Policy. 2010;21(5):335\u201342.","journal-title":"Int J Drug Policy"},{"issue":"12","key":"18-1_CR36","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.2105\/AJPH.84.12.1991","volume":"84","author":"EH Kaplan","year":"1994","unstructured":"Kaplan EH, Khoshnood K, Heimer R. A decline in HIV-infected needles returned to New Haven\u2019s needle exchange program: client shift or needle exchange? Am J Public Health. 1994;84(12):1991\u20134.","journal-title":"Am J Public Health"},{"issue":"5","key":"18-1_CR37","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s11904-017-0363-y","volume":"14","author":"MC Kennedy","year":"2017","unstructured":"Kennedy MC, Karamouzian M, Kerr T. Public health and public order outcomes associated with supervised drug consumption facilities: a systematic review. Curr HIV\/AIDS Rep. 2017;14(5):161\u201383.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"10\u201312","key":"18-1_CR38","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1080\/10826080600846219","volume":"41","author":"K Ksobiech","year":"2006","unstructured":"Ksobiech K. Beyond needle sharing: meta-analyses of social context risk behaviors of injection drug users attending needle exchange programs. Subst Use Misuse. 2006;41(10\u201312):1379\u201394.","journal-title":"Subst Use Misuse"},{"key":"18-1_CR39","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.drugalcdep.2018.11.033","volume":"197","author":"JA Kwon","year":"2019","unstructured":"Kwon JA, Iversen J, Law M, Dolan K, Wand H, Maher L. Estimating the number of people who inject drugs and syringe coverage in Australia, 2005\u20132016. Drug Alcohol Depend. 2019;197:108\u201314.","journal-title":"Drug Alcohol Depend"},{"issue":"1\u20132","key":"18-1_CR40","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1080\/096382800297123","volume":"22","author":"CJ Lennings","year":"2000","unstructured":"Lennings CJ. Harm minimization or abstinence: an evaluation of current policies and practices in the treatment and control of intravenous drug using groups in Australia. Disabil Rehabil. 2000;22(1\u20132):57\u201364.","journal-title":"Disabil Rehabil"},{"issue":"5","key":"18-1_CR41","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.amepre.2021.04.017","volume":"61","author":"TW Levengood","year":"2021","unstructured":"Levengood TW, Yoon GH, Davoust MJ, Ogden SN, Marshall BDL, Cahill SR, et al. Supervised injection facilities as harm reduction: a systematic review. Am J Prev Med. 2021;61(5):738\u201349.","journal-title":"Am J Prev Med"},{"key":"18-1_CR42","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/1471-2458-5-136","volume":"5","author":"S Logez","year":"2005","unstructured":"Logez S, Hutin Y, Somda P, Thuault J, Holloway K. Safer injections following a new national medicine policy in the public sector, Burkina Faso 1995\u20132000. BMC Public Health. 2005;5:136.","journal-title":"BMC Public Health"},{"key":"18-1_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2015.03.002","volume":"151","author":"Z Marshall","year":"2015","unstructured":"Marshall Z, Dechman MK, Minichiello A, Alcock L, Harris GE. Peering into the literature: a systematic review of the roles of people who inject drugs in harm reduction initiatives. Drug Alcohol Depend. 2015;151:1\u201314.","journal-title":"Drug Alcohol Depend"},{"issue":"12","key":"18-1_CR44","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/j.drugpo.2015.09.011","volume":"26","author":"A McAuley","year":"2015","unstructured":"McAuley A, Aucott L, Matheson C. Exploring the life-saving potential of naloxone: a systematic review and descriptive meta-analysis of take home naloxone (THN) programmes for opioid users. Int J Drug Policy. 2015;26(12):1183\u20138.","journal-title":"Int J Drug Policy"},{"issue":"7","key":"18-1_CR45","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1111\/add.13326","volume":"111","author":"R McDonald","year":"2016","unstructured":"McDonald R, Strang J. Are take-home naloxone programmes effective? Systematic review utilizing application of the Bradford Hill criteria. Addiction. 2016;111(7):1177\u201387.","journal-title":"Addiction"},{"issue":"6","key":"18-1_CR46","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1080\/16066350601002369","volume":"14","author":"N McKeganey","year":"2006","unstructured":"McKeganey N. The lure and the loss of harm reduction in UK drug policy and practice. Addict Res Theory. 2006;14(6):557\u201388.","journal-title":"Addict Res Theory"},{"key":"18-1_CR47","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.socscimed.2014.01.051","volume":"106","author":"R McNeil","year":"2014","unstructured":"McNeil R, Small W. Safer environment interventions: a qualitative synthesis of the experiences and perceptions of people who inject drugs. Soc Sci Med. 2014;106:151\u20138.","journal-title":"Soc Sci Med"},{"key":"18-1_CR48","volume-title":"Key substance use and mental health indicators in the United States: results from the 2018 National Survey on Drug Use and Health","author":"Mental Health Services Administration \u2013 SAMHSA","year":"2019","unstructured":"Mental Health Services Administration \u2013 SAMHSA. Key substance use and mental health indicators in the United States: results from the 2018 National Survey on Drug Use and Health. Rockville: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; 2019."},{"issue":"Suppl 2","key":"18-1_CR49","first-page":"S68","volume":"14","author":"MH Merson","year":"2000","unstructured":"Merson MH, Dayton JM, O\u2019Reilly K. Effectiveness of HIV prevention interventions in developing countries. AIDS. 2000;14(Suppl 2):S68\u201384.","journal-title":"AIDS"},{"issue":"1","key":"18-1_CR50","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12954-019-0327-1","volume":"16","author":"BE Meyerson","year":"2019","unstructured":"Meyerson BE, Lawrence CA, Cope SD, Levin S, Thomas C, Eldridge LA, et al. I could take the judgment if you could just provide the service: non-prescription syringe purchase experience at Arizona pharmacies, 2018. Harm Reduct J. 2019;16(1):57.","journal-title":"Harm Reduct J"},{"issue":"5","key":"18-1_CR51","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.sapharm.2019.08.026","volume":"16","author":"BE Meyerson","year":"2020","unstructured":"Meyerson BE, Agley JD, Jayawardene W, Eldridge LA, Arora P, Smith C, et al. Feasibility and acceptability of a proposed pharmacy-based harm reduction intervention to reduce opioid overdose, HIV and hepatitis C. Res Social Adm Pharm. 2020;16(5):699\u2013709.","journal-title":"Res Social Adm Pharm"},{"issue":"1","key":"18-1_CR52","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/epirev\/mxaa003","volume":"42","author":"B Moazen","year":"2020","unstructured":"Moazen B, Dolan K, Saeedi Moghaddam S, Lotfizadeh M, Duke K, Neuhann F, et al. Availability, accessibility, and coverage of needle and syringe programs in prisons in the European Union. Epidemiol Rev. 2020;42(1):19\u201326.","journal-title":"Epidemiol Rev"},{"issue":"2","key":"18-1_CR53","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1080\/08897077.2015.1010032","volume":"36","author":"SR Mueller","year":"2015","unstructured":"Mueller SR, Walley AY, Calcaterra SL, Glanz JM, Binswanger IA. A review of opioid overdose prevention and naloxone prescribing: implications for translating community programming into clinical practice. Subst Abus. 2015;36(2):240\u201353.","journal-title":"Subst Abus"},{"key":"18-1_CR54","first-page":"19","volume-title":"Needle and syringe programmes \u2013 NICE public health guidance","author":"National Institute for Health and Care Excellence \u2013 NICE","year":"2014","unstructured":"National Institute for Health and Care Excellence \u2013 NICE. Needle and syringe programmes \u2013 NICE public health guidance. London: National Institute for Health and Care Excellence 2014;52(11). 19."},{"key":"18-1_CR55","volume-title":"Gay Men\u2019s Health Crisis. Syringe exchange programs around the world: global context","author":"M O\u2019Shea","year":"2009","unstructured":"O\u2019Shea M, Malsbury S, Mennerich D, Stinson J. Gay Men\u2019s Health Crisis. Syringe exchange programs around the world: global context. New York: Gay Men\u2019s Health Crisis; 2009. https:\/\/www.nypl.org\/sites\/default\/files\/archivalcollections\/pdf\/1126.pdf"},{"key":"18-1_CR56","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jclinepi.2017.10.017","volume":"94","author":"MJ Page","year":"2018","unstructured":"Page MJ, Altman DG, Shamseer L, McKenzie JE, Ahmadzai N, Wolfe D, et al. Reproducible research practices are underused in systematic reviews of biomedical interventions. J Clin Epidemiol. 2018;94:8\u201318.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"18-1_CR57","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12954-021-00517-0","volume":"18","author":"RA Parry","year":"2021","unstructured":"Parry RA, Zule WA, Hurt CB, Evon DM, Rhea SK, Carpenter DM. Pharmacist attitudes and provision of harm reduction services in North Carolina: an exploratory study. Harm Reduct J. 2021;18(1):70.","journal-title":"Harm Reduct J"},{"key":"18-1_CR58","first-page":"CD012021","volume":"9","author":"L Platt","year":"2017","unstructured":"Platt L, Minozzi S, Reed J, Vickerman P, Hagan H, French C, et al. Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs. Cochrane Database Syst Rev. 2017;9:CD012021.","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"18-1_CR59","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/add.14012","volume":"113","author":"L Platt","year":"2018","unstructured":"Platt L, Minozzi S, Reed J, Vickerman P, Hagan H, French C, et al. Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane review and meta-analysis. Addiction. 2018;113(3):545\u201363.","journal-title":"Addiction"},{"issue":"1","key":"18-1_CR60","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1477-7517-1-6","volume":"1","author":"K Roberts","year":"2004","unstructured":"Roberts K, Hunter C. A comprehensive system of pharmaceutical care for drug misusers. Harm Reduct J. 2004;1(1):6.","journal-title":"Harm Reduct J"},{"key":"18-1_CR61","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.drugpo.2017.05.012","volume":"45","author":"E Roy","year":"2017","unstructured":"Roy E, Arruda N, Leclerc P, Morissette C, Blanchette C, Blouin K, et al. Drug use practices among people who inject drugs in a context of drug market changes: challenges for optimal coverage of harm reduction programs. Int J Drug Policy. 2017;45:18\u201324.","journal-title":"Int J Drug Policy"},{"issue":"3","key":"18-1_CR62","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1521\/aeap.2010.22.3.238","volume":"22","author":"AE Rudolph","year":"2010","unstructured":"Rudolph AE, Standish K, Amesty S, Crawford ND, Stern RJ, Badillo WE, et al. A community-based approach to linking injection drug users with needed services through pharmacies: an evaluation of a pilot intervention in New York City. AIDS Educ Prev. 2010;22(3):238\u201351.","journal-title":"AIDS Educ Prev"},{"issue":"2","key":"18-1_CR63","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/add.13593","volume":"112","author":"R Sawangjit","year":"2017","unstructured":"Sawangjit R, Khan TM, Chaiyakunapruk N. Effectiveness of pharmacy-based needle\/syringe exchange programme for people who inject drugs: a systematic review and meta-analysis. Addiction. 2017;112(2):236\u201347.","journal-title":"Addiction"},{"issue":"1","key":"18-1_CR64","first-page":"113","volume":"24","author":"P Sendziuk","year":"2007","unstructured":"Sendziuk P. Harm reduction and HIV-prevention among injecting drug users in Australia: an international comparison. Can Bull Med Hist. 2007;24(1):113\u201329.","journal-title":"Can Bull Med Hist"},{"key":"18-1_CR65","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1477-7517-2-10","volume":"2","author":"J Sheridan","year":"2005","unstructured":"Sheridan J, Henderson C, Greenhill N, Smith A. Pharmacy-based needle exchange in New Zealand: a review of services. Harm Reduct J. 2005;2:10.","journal-title":"Harm Reduct J"},{"issue":"1","key":"18-1_CR66","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.drugpo.2013.05.011","volume":"25","author":"S Singh","year":"2014","unstructured":"Singh S, Ambrosio M, Semini I, Tawil O, Saleem M, Imran M, et al. Revitalizing the HIV response in Pakistan: a systematic review and policy implications. Int J Drug Policy. 2014;25(1):26\u201333.","journal-title":"Int J Drug Policy"},{"key":"18-1_CR67","unstructured":"Steenholdt D, Colquhoun R, Varcoe S. 30\u00a0Years of harm minimisation \u2013 how far have we come? Evidence based review of the influence and impact on drug use in Australia under the \u2018Harm Minimisation Strategy\u2019. Dalgarno Institute. 2015. https:\/\/www.unodc.org\/documents\/ungass2016\/Contributions\/Civil\/Dalgarno\/30Years_of_HarmMinimisation_FinalUNGASS.pdf"},{"issue":"3","key":"18-1_CR68","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/S2215-0366(16)00002-X","volume":"3","author":"E Stockings","year":"2016","unstructured":"Stockings E, Hall WD, Lynskey M, Morley KI, Reavley N, Strang J, et al. Prevention, early intervention, harm reduction, and treatment of substance use in young people. Lancet Psychiatry. 2016;3(3):280\u201396.","journal-title":"Lancet Psychiatry"},{"issue":"8","key":"18-1_CR69","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001496","volume":"10","author":"AB Suthar","year":"2013","unstructured":"Suthar AB, Ford N, Bachanas PJ, Wong VJ, Rajan JS, Saltzman AK, et al. Towards universal voluntary HIV testing and counselling: a systematic review and meta-analysis of community-based approaches. PLoS Med. 2013;10(8):e1001496.","journal-title":"PLoS Med"},{"issue":"1","key":"18-1_CR70","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12954-021-00524-1","volume":"18","author":"K Thakarar","year":"2021","unstructured":"Thakarar K, Sankar N, Murray K, Lucas FL, Burris D, Smith RP. Injections and infections: understanding syringe service program utilization in a rural state. Harm Reduct J. 2021;18(1):74.","journal-title":"Harm Reduct J"},{"key":"18-1_CR71","unstructured":"The Ontario Drug Policy Research Network \u2013 ODPRN. The Office of the Chief Coroner for Ontario\/Ontario Forensic Pathology Service, Public Health Ontario, & Centre on Drug Policy Evaluation. Preliminary patterns in circumstances surrounding opioid-related deaths in Ontario during the COVID-19 pandemic. 2020. Available at https:\/\/odprn.ca\/wp-content\/uploads\/2020\/11\/Opioid-Death-Report_FINAL-2020NOV09.pdf. Accessed 10 Jan 2022."},{"key":"18-1_CR72","unstructured":"The Pharmacy Guild of Australia. Community pharmacy roadmap program development template. Needle and syringe program Barton: The Pharmacy Guild of Australia. 2010. https:\/\/www.guild.org.au\/__data\/assets\/pdf_file\/0026\/4769\/here-.pdf"},{"key":"18-1_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.102866","volume":"84","author":"LT Tran","year":"2020","unstructured":"Tran LT, Peacock A, Colledge S, Memedovic S, Grebely J, Leung J, et al. Injecting risk behaviours amongst people who inject drugs: a global multi-stage systematic review and meta-analysis. Int J Drug Policy. 2020;84:102866.","journal-title":"Int J Drug Policy"},{"issue":"11","key":"18-1_CR74","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1111\/j.1360-0443.2011.03515.x","volume":"106","author":"KM Turner","year":"2011","unstructured":"Turner KM, Hutchinson S, Vickerman P, Hope V, Craine N, Palmateer N, et al. The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence. Addiction. 2011;106(11):1978\u201388.","journal-title":"Addiction"},{"key":"18-1_CR75","unstructured":"U.S. Agency for International Development \u2013 USAID. Needle and syringe programs rigorous evidence \u2013 usable results USAID. 2010. Available from: https:\/\/www.jhsph.edu\/research\/centers-and-institutes\/research-to-prevention\/publications\/needleandsyringe.pdf. Accessed 23 Aug 2021."},{"key":"18-1_CR76","unstructured":"United Nations Office on Drugs and Crime (UNODC). Number and prevalence of PWID and those living with HIV among this group. 2017. Available at. https:\/\/dataunodcun.org\/drugs\/pwid_hiv-2017"},{"issue":"6","key":"18-1_CR77","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1097\/00002030-199806000-00012","volume":"12","author":"EJ van Ameijden","year":"1998","unstructured":"van Ameijden EJ, Coutinho RA. Maximum impact of HIV prevention measures targeted at injecting drug users. AIDS. 1998;12(6):625\u201333.","journal-title":"AIDS"},{"issue":"Suppl A","key":"18-1_CR78","first-page":"S75","volume":"9","author":"EJ van Ameijden","year":"1995","unstructured":"van Ameijden EJ, Watters JK, van den Hoek JA, Coutinho RA. Interventions among injecting drug users: do they work? AIDS. 1995;9(Suppl A):S75\u201384.","journal-title":"AIDS"},{"issue":"7","key":"18-1_CR79","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25583","volume":"23","author":"TI Vasylyeva","year":"2020","unstructured":"Vasylyeva TI, Smyrnov P, Strathdee S, Friedman SR. Challenges posed by COVID-19 to people who inject drugs and lessons from other outbreaks. J Int AIDS Soc. 2020;23(7):e25583.","journal-title":"J Int AIDS Soc"},{"key":"18-1_CR80","unstructured":"World Health Organization \u2013 WHO. Integrated screening for infectious diseases: a success story from Georgia. 2021. Available at https:\/\/www.euro.who.int\/en\/countries\/georgia\/news\/news\/2021\/5\/integrated-screening-for-infectious-diseases-a-success-story-from-georgia. Accessed 12 Jan 2022."},{"key":"18-1_CR81","volume-title":"Drug, set and setting: the basis for controlled intoxicant use","author":"N Zinberg","year":"1984","unstructured":"Zinberg N. Drug, set and setting: the basis for controlled intoxicant use. Boston: Yale University Press; 1984."}],"container-title":["Encyclopedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-50247-8_18-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T15:25:53Z","timestamp":1725549953000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-030-50247-8_18-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9783030502478","9783030502478"],"references-count":81,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-50247-8_18-1","relation":{},"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"24 January 2022, 00:00:00","order":1,"name":"received","label":"Received","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"1 October 2022, 00:00:00","order":2,"name":"accepted","label":"Accepted","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"11 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}